RxDoctor Payments Data

Geoffrey Coker, NP

Nurse Practitioner · Plainfield, INNPI 1801234513

Payments from drug & device makers

$986in general payments, 2019–2025

Across 26 payments — averaging $37.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teladoc Health, Inc.$450
  • AbbVie$185
  • Lilly USA, LLC$88
  • Boehringer Ingelheim$43
  • Novo Nordisk$33
  • Astellas Pharma US Inc$28
  • plus $158 from 9 others

What the payments were for

  • Consulting fees$25025%
  • Speaking & faculty fees$20020%
  • Food & beverage$53654%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$986 in reported general payments places this provider in the 70th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$7,727
Medicare patients
64
Services billed
108

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide83$108,696
OzempicSemaglutide31$55,511
Trelegy ElliptaFluticasone/Umeclidin/Vilanter43$34,600
EliquisApixaban20$26,079
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$10,100
Dexlansoprazole DrDexlansoprazole23$5,977
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$3,445
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen60$1,667
Desvenlafaxine Succinate ErDesvenlafaxine Succinate18$1,629
Atorvastatin Calcium155$1,228
Pantoprazole Sodium52$1,028
Albuterol Sulfate HfaAlbuterol Sulfate43$955
Gabapentin75$896
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$679
Venlafaxine Hcl ErVenlafaxine Hcl16$670

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$88$108,69683 claims
Novo NordiskOzempic$33$55,51131 claims
GSKTrelegy Ellipta$19$34,60043 claims
PfizerEliquis$17$26,07920 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Plainfield

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →